Search clinical trials for: Anti-Retroviral Agents

Total 189360 results

Evandro Chagas National Institute of Infectious...
Beatriz Grinsztejn; Thiago Torres; Valdilea Gonçalves; Brenda Hoagland

Not yet recruiting

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir (ImPrepCab)

HIV Infections

Brazil
Chelsea and Westminster NHS Foundation Trust

Recruiting

Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch (DORDOL)

HIV-1-infection

United Kingdom
University of KwaZulu
Centre for the AIDS Programme of Research in South Africa

Recruiting

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB (ORCHID)

Tuberculosis | Hiv

South Africa
Janssen Research & Development, LLC

Completed

A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed

HIV

Italy, Thailand, Spain, Uganda, Portugal, South Africa
University of Minnesota
American College of Clinical Pharmacy

Completed

Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract

HIV/AIDS | Menopause | Inflammation Vagina

United States
University Health Network, Toronto
Gilead Sciences

Completed

Use of TDF in Patients With Inactive Chronic Hepatitis B Infection

Hepatitis B, Chronic

Canada
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

HIV Infections

United States, Kenya, South Africa, Thailand
Helsinki University Central Hospital
Merck Sharp & Dohme LLC

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir (OBERAL)

Fatty Liver | Metabolic Syndrome | HIV Seropositivity

Finland
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Tenofovir Rectal Douche to Prevent HIV Transmission (DREAM-03)

HIV/AIDS | HIV Prevention

United States
University of Colorado, Denver

Completed

Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Hepatitis C | HIV

United States
Centers for Disease Control and Prevention
Ministry of Health, Thailand; Bangkok Metropolitan Administration Medical College...

Completed

Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand

HIV Infections

Thailand
Imperial College London
Institut National de la Santé Et de la Recherche Médicale, France; Medical... and other collaborators

Completed

PROLIFICA - West African Treatment Cohort for Hepatitis B (WATCH)

Hepatocellular Carcinoma | Hepatitis B, Chronic

Gambia, Senegal
Thomas Jefferson University
Gilead Sciences

Active, not recruiting

Entecavir to TAF Switch

Hepatitis B

United States
F-star Therapeutics, Inc.

Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (ACHIEVE)

Hepatitis B | Hepatitis, Viral

Canada, Hong Kong, Korea, Republic of, Taiwan
PATH
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (TMC278LA)

Human Immunodeficiency Virus (HIV)

United States, South Africa, Zimbabwe
University Of Perugia

Completed

Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.

Inflammation | Atherosclerosis | Cardiovascular Risk Factor | HIV Infection With Other Conditions

Italy
Janssen Korea, Ltd., Korea

Completed

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Acquired Immune Deficiency Syndrome

Korea, Republic of
ViiV Healthcare
GlaxoSmithKline

Completed

Fosamprenavir Expanded Access

Infection, Human Immunodeficiency Virus

Switzerland
Hoffmann-La Roche
Trimeris

Completed

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

HIV Infections

United States, Australia
The University of Hong Kong

Completed

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

Hepatitis B, Chronic

China
E-DA Hospital
Taipei Institute of Pathology

Unknown

Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B

Chronic Hepatitis B | Antiviral Treatment
Hoffmann-La Roche

Completed

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

HIV Infections

France
Maastricht Radiation Oncology

Completed

Nelfinavir, a Phase I/Phase II Rectal Cancer Study (Nelfinavir)

Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

Netherlands
ViiV Healthcare
GlaxoSmithKline

Completed

Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers

Infection, Human Immunodeficiency Virus

United States
National Center for Global Health and Medicine,...

Completed

Safety Study of Maraviroc's Effect on Human Osteoclasts (MVC-Bone)

HIV Infections | AIDS

Japan
Novartis Pharmaceuticals

Completed

A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

Hepatitis B, Chronic

Argentina, Brazil, Germany, Thailand
Germans Trias i Pujol Hospital

Completed

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

HIV Infections | HIV

Spain
Janssen-Cilag International NV

Completed

Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir (MONET)

HIV Infections | Human Immunodeficiency Virus | Acquired Immunodeficiency Syndrome Virus | AIDS Virus

United Kingdom, Belgium, Germany, Spain, Portugal, Israel, Denmark, Russian Federation, Austria, Hungary, Switzerland
Avexa

Terminated

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

HIV Infections

Canada, United States, Australia, United Kingdom, Thailand, Germany, Italy, Israel, Belgium, Puerto Rico, Peru
Bristol-Myers Squibb

Completed

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb

Completed

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

HIV Infections

United States, Puerto Rico
Tibotec Pharmaceuticals, Ireland

Completed

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

HIV-I
Pfizer

Completed

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

HIV Infections
Pharmasset

Completed

A Study of DPC 817 in HIV-Infected Males

HIV Infections

United States, Germany
Hoffmann-La Roche

Completed

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

HIV Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study of L-735,524 in HIV-Positive Children and Adolescents

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of 1592U89 in HIV-Infected Children

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications

HIV Infections

United States
Seoul National University Hospital
Gilead Sciences; Konkuk University Hospital

Unknown

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma, Burkitt's

Korea, Republic of
Tokyo Women's Medical University

Completed

Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases

Kidney Cancer | Metastatic Cancer

Japan
National Eye Institute (NEI)

Completed

Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease

Niemann Pick Diseases

United States, United Kingdom
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2) (MIG-2)

Contraception

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

HIV Infections
Chinese University of Hong Kong
GlaxoSmithKline; Hoffmann-La Roche

Completed

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
National Taiwan University Hospital
Chiayi Christian Hospital; E-DA Hospital; Taipei City Hospital; Taipei Tzu Chi... and other collaborators

Recruiting

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue (CHANGE)

Chronic Hepatitis b | Hepatitis B Reactivation

Taiwan
Tongji Hospital
Gilead Sciences

Recruiting

TAF Real World Study for Universal Effectiveness (TRUE)

Chronic Hepatitis b

China
University of Liverpool
Radboud University Medical Center; University of Cape Town; UNITAID; Liverpool... and other collaborators

Completed

Dolutegravir in Pregnant HIV Mothers and Their Neonates (DolPHIN-2)

Pregnancy Related | HIV-1-infection

Uganda, South Africa

Search clinical trials for: Anti-Retroviral Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations